Usefulness of Claudin 4 in the cytological diagnosis of serosal effusions

Diagnostic Cytopathology

Volumn 39, Issue 5, 2011, Pages 313-317

  Lonardi, Silvia ^a,b   Manera, Calogero ^a   Marucci, Raffaella ^a   Santoro, Amerigo ^a   Lorenzi, Luisa ^a   Facchetti, Fabio ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Spedali Civili Brescia ^*  (Italy)

Author keywords

Claudin 4; diagnosis; immunocytochemistry; mesothelioma; metastatic effusions

Indexed keywords

CLAUDIN 4;

ARTICLE; BREAST TUMOR; CONTROLLED STUDY; CYTODIAGNOSIS; EFFUSION; EPITHELIAL METASTASIS; FEMALE GENITAL TRACT TUMOR; GASTROINTESTINAL TUMOR; HUMAN; LUNG TUMOR; MESOTHELIOMA; MESOTHELIUM CELL; METASTASIS; PERICARDIUM; PERITONEUM; PERITONEUM TUMOR; PLEURA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROSAL EFFUSION; TUMOR CELL;

ASCITIC FLUID; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; NEOPLASMS, GLANDULAR AND EPITHELIAL; NEOPLASMS, MESOTHELIAL; PERICARDIAL EFFUSION; PLEURAL EFFUSION; SEROUS MEMBRANE; TUMOR MARKERS, BIOLOGICAL;

EID: 79954563507     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21380     Document Type: Article

References (27)

1. Monte SA, Ehya H, Lang WR,. Positive effusion cytology as the initial presentation of malignancy. Acta Cytol 1987; 31: 448-452. (Pubitemid 17126855)
2. Suster S, Moran CA,. Applications and limitations of immunohistochemistry in the diagnosis of malignant mesothelioma. Adv Anat Pathol 2006; 13: 316-329. (Pubitemid 44673447)
3. Addis B, Roche H,. Problems in mesothelioma diagnosis. Histopathology 2009; 54: 55-68.
4. Lozano MD, Panizo A, Toledo GR, Sola JJ, Pardo-Mindan J,. Immunocytochemistry in the differential diagnosis of serous effusions: A comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears. Cancer 2001; 93: 68-72.
5. Politi E, Kandaraki C, Apostolopoulou C, Kyritsi T, Koutselini H,. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids. Diagn Cytopathol 2005; 32: 151-155. (Pubitemid 40256264)
6. Pereira TC, Saad RS, Liu Y, Silverman JF,. The diagnosis of malignancy in effusion cytology: A pattern recognition approach. Adv Anat Pathol 2006; 13: 174-184. (Pubitemid 44341653)
7. King JE, Thatcher N, Pickering CA, Hasleton PS,. Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: A detailed systematic analysis using published data. Histopathology 2006; 48: 223-232.
8. Murugan P, Siddaraju N, Habeebullah S, Basu D,. Immunohistochemical distinction between mesothelial and adenocarcinoma cells in serous effusions: A combination panel-based approach with a brief review of the literature. Indian J Pathol Microbiol 2009; 52: 175-181.
9. Facchetti F, Lonardi S, Gentili F, Bercich L, Falchetti M, Tardanico R, Baronchelli C, Lucini L, Santin A, Murer B,. Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions. Virchows Arch 2007; 451: 669-680. (Pubitemid 47340982)
10. Bedrossian CW,. Special stains, the old and the new: The impact of immunocytochemistry in effusion cytology. Diagn Cytopathol 1998; 18: 141-149. (Pubitemid 28087017)
11. Ruitenbeek T, Gouw AS, Poppema S,. Immunocytology of body cavity fluids. MOC-31, a monoclonal antibody discriminating between mesothelial and epithelial cells. Arch Pathol Lab Med 1994; 118: 265-269. (Pubitemid 24093652)
12. Dejmek A, Hjerpe A,. Reactivity of six antibodies in effusions of mesothelioma, adenocarcinoma and mesotheliosis: Stepwise logistic regression analysis. Cytopathology 2000; 11: 8-17. (Pubitemid 30106433)
13. Attanoos RL, Webb R, Dojcinov SD, Gibbs AR,. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum. Histopathology 2002; 40: 237-244. (Pubitemid 34227114)
14. Davidson B, Risberg B, Kristensen G, Kvalheim G, Emilsen E, Bjamer A, Berner A,. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers. Virchows Arch 1999; 435: 43-49. (Pubitemid 29346741)
15. Fetsch PA, Abati A,. Immunocytochemistry in effusion cytology: A contemporary review. Cancer 2001; 93: 293-308. (Pubitemid 32995213)
16. Nichols LS, Ashfaq R, Iacobuzio-Donahue CA,. Claudin 4 protein expression in primary and metastatic pancreatic cancer: Support for use as a therapeutic target. Am J Clin Pathol 2004; 121: 226-230. (Pubitemid 38140127)
17. Ueda J, Semba S, Chiba H, Sawada N, Seo Y, Kasuga M, Yokozaki H,. Heterogeneous expression of Claudin-4 in human colorectal cancer: Decreased Claudin-4 expression at the invasive front correlates cancer invasion and metastasis. Pathobiology 2007; 74: 32-41. (Pubitemid 46745168)
18. Soini Y,. Expression of Claudins 1, 2, 3, 4, 5 and 7 in various types of tumours. Histopathology 2005; 46: 551-560. (Pubitemid 40632312)
19. Zhu Y, Brannstrom M, Janson PO, Sundfeldt K,. Differences in expression patterns of the tight junction proteins, Claudin 1, 3, 4 and 5, in human ovarian surface epithelium as compared to epithelia in inclusion cysts and epithelial ovarian tumours. Int J Cancer 2006; 118: 1884-1891.
20. Sheehan GM, Kallakury BV, Sheehan CE, Fisher HA, Kaufman RP, Jr, Ross JS,. Loss of Claudins-1 and -7 and expression of Claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas. Hum Pathol 2007; 38: 564-569. (Pubitemid 46399893)
21. Pan XY, Wang B, Che YC, Weng ZP, Dai HY, Peng W,. Expression of Claudin-3 and Claudin-4 in normal, hyperplastic, and malignant endometrial tissue. Int J Gynecol Cancer 2007; 17: 233-241. (Pubitemid 46213996)
22. Long H, Crean CD, Lee WH, Cummings OW, Gabig TG,. Expression of Clostridium perfringens enterotoxin receptors Claudin-3 and Claudin-4 in prostate cancer epithelium. Cancer Res 2001; 61: 7878-7881. (Pubitemid 33049378)
23. Hewitt KJ, Agarwal R, Morin PJ,. The Claudin gene family: Expression in normal and neoplastic tissues. BMC Cancer 2006; 6: 186.
24. Lodi C, Szabo E, Holczbauer A, et al. Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas. Mod Pathol 2006; 19: 460-469. (Pubitemid 43277001)
25. Falconieri G, Zanconati F, Colautti I, Dudine S, Bonifacio-Gori D, Di Bonito L,. Effusion cytology of hepatocellular carcinoma. Acta Cytol 1995; 39: 893-897.
26. Tavassoli FA, Devilee P, editor. WHO classification of tumours. Pathology and genetics of tumours of the breast and female genitale organs. Lyon: IARC; 2003. p 113-202.
27. Kleinberg L, Holth A, Fridman E, Schwartz I, Shih Ie M, Davidson B,. The diagnostic role of Claudins in serous effusions. Am J Clin Pathol 2007; 127: 928-937.